Growing market for generics and liberalization of OTC medicines driving demand at CPHI Japan 2017
PIC/S membership accelerating international interest with market forecast to reach US$115bn by 2024.
CPHI Japan – organised by UBM EMEA and UBM Japan – returns to the Tokyo Big Sight Centre for its 16th edition, 19-21 April 2017. Gathering over 19,600 attendees and 550 exhibitors from 30 countries, the show will co-locate with ICSE, P-MEC, BioPh, and InnoPack. An ageing population, a growing generics market and liberalization of OTC medicines make Japan an attractive destination for investments, particularly as the pharma industry undergoes legislative change, with the Government’s bid to cut healthcare expenditure.
Central to the internationalisation of the Japanese market is CPHI Japan, which returns as the most comprehensive pharma event in the region to provide the latest trends, insights and innovations in the industry. The five-in-one event allows visitors to gain access to the entire Japanese pharma industry under one roof, and meet with exhibitors working across ingredients, contract services, biopharmaceuticals, machinery, technology, and packaging.
Japan is the world’s third largest pharma industry, with a market that is forecasted to reach a total value of US $115 billion by 2024. However, due to an ageing population and growing healthcare costs, the Government recently committed to increase market penetration of generics from 30% in 2014, to 60% by the end of this year. The surge in demand will open up new opportunities for international pharmaceutical manufacturers, as domestic producers alone will struggle to meet required capacity. High quality Indian generic manufacturers and branded generics, particularly those from the US and Europe, are well placed to expand market share.
Having joined the Pharmaceutical Inspection Convention and the Pharmaceutical Inspection Cooperation Scheme (PIC/S) in 2014, Japan is also synchronising manufacturing and quality control standards between overseas suppliers and Japanese pharmaceutical manufacturers.
“Entering the PIC/S system 3 years ago has accelerated the entry to market for several international companies, particularly as the synchronisation of standards harmonise procedures. This coupled with the rise in demand for generics and the price review frequency amendment, will see pharma manufacturers from places such as India, but also Europe and the US cement a foothold in Japanese pharma, as consumers here are highly brand oriented.” Rutger Oudejans, Brand Director CPHI at UBM EMEA.
To help explore the market’s potential, running alongside the exhibition is a three-day, in-depth conference. CPHI Japan’s high-value conference programme enables attendees to learn about the latest trends and strategies in the market. It features bespoke content discussions and special seminars across topics such as ‘An Evolving Pharma Market - Challenges and Opportunities Ahead - Outlook to 2021’, and ‘Digital health: What does it mean exactly?’.
In addition, keynote sessions will address ‘Current situations and challenges of policy on health insurance’ and ‘Current topics regarding regulation of pharmaceuticals in Japan’. Finally, an important session, dedicated to the new pricing and reimbursement system of medicines set in December 2016, will discuss the effects this will have in the market, including the potential reduction in overall prices and increased competition.
Oudejans added: “With the Japanese market becoming increasingly accessible to international companies, CPHI Japan is vital not only to meet and network with future partners, but also to learn about the key trends and insights in the pharma market. We have tailored our platforms, and particularly CPHI Japan’s conference programme, to provide the most important topics and information needed to thrive in this pharma economy. For the past 16 years, we have seen this industry grow and it is now opening up to international markets and generics in addition to having one of the world’s highest per capita pharma spends.”
Other notable features at CPHI Japan 2017 includeRelated News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance